...
首页> 外文期刊>Current medicinal chemistry >Known Triterpenes and their Derivatives as Scaffolds for the Development of New Therapeutic Agents for Cancer
【24h】

Known Triterpenes and their Derivatives as Scaffolds for the Development of New Therapeutic Agents for Cancer

机译:已知的Triterpenes及其衍生物作为用于癌症新治疗剂的脚手架

获取原文
获取原文并翻译 | 示例

摘要

Background: Plants produce several bioactive secondary metabolites whose are used as therapeutic agents to treat several diseases, among whom cancer. Triterpenes are secondary metabolites that exert inhibitory activity against multiple intracellular and extracellular targets in euchariotic cells. These targets are proteins involved in apoptosis, cell development and differentiation, angiogenesis, metastasis and inflammatory processes. The inhibition of their functions leads to decreased cellular growth, differentiation and migration, resulting in antitumor activity, as shown by several authors. Furthermore, during recent years synthetic triterpenoid derivatives have also been developed to implement potency and efficacy of starting compounds, allowing the obtainment of new agents having promising anticancer activity.
机译:背景:植物产生几种生物活性次级代谢物,其用作治疗剂治疗几种疾病,其中癌症。 Triterpenes是次级代谢产物,其在一次性细胞中施加对多个细胞内和细胞外靶标的抑制活性。 这些靶标是参与细胞凋亡,细胞发育和分化,血管生成,转移和炎症过程的蛋白质。 其功能的抑制导致细胞生长,分化和迁移降低,导致抗肿瘤活性,如若干作者所示。 此外,在近年来,还制定了合成三萜类衍生物以实施起始化合物的效力和功效,从而允许获得具有抗癌活性的新试剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号